Ledger.Open graph →
SEC Form D · filed January 13, 2021

Sparrow Pharmaceuticals, Inc

Offering
$50.8M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Katz · NEW YORK, NYExecDavid Katz · Chicago, ILExecRobert Jacks · Portland, ORExec · DirectorPeter Thompson · Seattle, WADirectorKlaus Veitinger · New York, NYDirectorDavid Katz · Chicago, ILExecRobert Jacks · Newark, NJExec · DirectorPeter Thompson · New York, NYDirectorKlaus Veitinger · Newark, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗